S.E.A. Medical Improves IV Drug Delivery

S.E.A. Medical Systems, Inc. is a privately held medical device company developing solutions for making intravenous (IV) drug delivery safer for patients. The Company uses its proprietary technology to rapidly measure multiple parameters of the IV fluid to identify the drug, concentration and diluent. The mechanisms contain sensors, which are made by a process with reproducible, large volume, cost-effective manufacturing. Instantaneous measurements do not alter the IV fluid, and can be used for single sample measurements or continuous monitoring.

The first commercial product, IV Check, is in development, to validate that IV preparations are correct and safe, and measure pharmacy returns to detect narcotic or scheduled drug diversion. Additional concepts for IV safety and management are in development as well.

The Products

IV Check – measures IV samples in the hospital pharmacy or anywhere IVs are prepared, and instantly reports the drug, dose and diluent present to validate IVs and avoid mistakes that can injure or kill patients.

Smart IV – monitors the IV administration to the patient, ensuring that nurses know exactly what is being administered and alerting them to errors in IV delivery, before they harm patients.

Auto IV – uses the same technolgy implementation as Smart IV, but takes it a step further and controls the IV administration to the patient by automatically sensing the drug(s) and setting appropriate administration conditions from safety guidelines and/or the patients’ electronic medical records, ensuring that patients receive the appropriate medications at the appropriate doses, rates and times.

IV Waste – systems automate documentation and segregation of EPA regulated pharmaceutical waste streams and document disposal of scheduled drugs like narcotics for DEA compliance. Because it deals with post-patient IVs, IV Waste does not require regulatory approval.

To learn more about S.E.A. Medical technology, visit their website.

The Institute of Medicine (IOM) of the National Academies Committee on Identifying and Preventing Medication Errors estimated that at least 1.5 million preventable ADEs occur each year in the United States. Medication errors alone, occurring either in or out of the hospital, are estimated to account for 7,000 deaths annually.

S.E.A. Medical will be presenting its products and technologies at OneMedForum SF 2012, on January 9 – 12.